Pulmonx (LUNG) Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Payables data on file, last reported at $4.0 million in Q4 2025.

• Payables for Q4 2025 came in at $4.0 million, down 42.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.0 million (down 42.72% YoY), and the FY2025 annual result was $4.0 million, down 42.72% from the prior year.
• Payables fell to $4.0 million in Q4 2025 per LUNG's latest filing, from $6.5 million in the prior quarter.
• Over five years, Payables peaked at $18.9 million in Q4 2021 and troughed at $1.8 million in Q4 2022.
• A 5-year average of $7.8 million and a median of $6.0 million in 2022 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables plunged 90.23% in 2022, then jumped 180.31% in 2024.
• A 5-year view of Payables shows it stood at $18.9 million in 2021, then sank by 90.23% to $1.8 million in 2022, then surged by 97.62% to $3.7 million in 2023, then soared by 91.76% to $7.0 million in 2024, then tumbled by 42.72% to $4.0 million in 2025.
• Business Quant data shows LUNG's Payables at $4.0 million in Q4 2025, $6.5 million in Q3 2025, and $6.7 million in Q2 2025.